Ivanova M.R., Khakunova M. Kh., Kablakhova N.O.
Center for Prevention and Control of AIDS and Infectious Diseases, Ministry of Health of the Kabardino-Balkar Republic, Nalchik, Russia
1. Zajcev A.A. [The choice of antibiotic for treatment of respiratory tract infections]. Consilium provisorum 2010; (1): 16–7. (In Russ.). 2. Yakovlev S.V., Sidorenko S.V., Rafal’skij V.V., Spichak T.V. (eds.) [Strategy and tactics for the rational use of antimicrobial agents in ambulatory practice. Russian practical recommendations]. Moscow: Presto Рubl.; 2014. 121 p. (In Russ.). 3. Septimus E.J., Kuper K.M. Clinical challenges in addressing resistance to antimicrobial drugs in the twentyfirst century. Clin. Pharmacol. Ther. 2009; 86(3): 336–9. 4. Kozlov R.S., Golub A.V. [The strategy of using antimicrobial agents as an attempt of the Renaissance of antibiotics]. Klinicheskaya Mikrobiologiya i Antimikrobnaya Himioterapiya 2011; 13(4): 322–34. (In Russ.). 5. A letter to President Obama and Swedish Prime Minister Reinfeldt [letter]. http://www.idsociety.org/WorkArea/DownloadAsset.aspx?id=15752. 6. Suhorukova M.V., Skleenova E.Yu., Ivanchik N.V., Timohova A.V., Ejdel’shtejn M.V., Dekhnich A.V., Kozlov R.S., issledovatel’skaya gruppa ≪MARAFON≫. [Antibiotic resistance of nosocomial strains of Staphylococcus aureus in hospitals of Russia: results of multicenter epidemiological study ≪MARATHON≫ in 2011–2012]. Klinicheskaya Mikrobiologiya i Antimikrobnaya Himioterapiya 2014; 16(4): 280–6. (In Russ.). 7. Tian Y., Li T., Zhu Y., Wang B., Zou X., Li M. Mechanisms of linezolid resistance in staphylococci and enterococci isolated from two teaching hospitals in Shanghai, China. BMC Microbiol. 2014; 14(1): 292–5. 8. Козлова Л.В., Мизерницкий Ю.Л., Галкина Е.В. Наиболее распространённые врачебные ошибки при пневмониях у детей (в настоящее время). Антибактериальная терапия внебольничной пневмонии у детей. Рос. вест. перинатол. и педиатр. 2005; (3): 9–11. Kozlova L.V., Mizernickij Yu.L., Galkina E.V. [The most common medical errors in pneumonia in children (currently). Antibacterial therapy of community-acquired pneumonia in children]. Rossiiskii Vestnik Perinatologii i Pediatrii 2005; (3): 9–11. (In Russ.). 9. McClure N.S., Day T. Slowing evolution is more effective than enhancing drug development for managing resistance. http://arxiv.org/abs/1304.7715.
For correspondence: Marina R. Ivanova, e-mail: marina19692003@list.ru